Medicare Begins to Rein In Drug Costs for Older Americans

U.S. Health Officials Seek New Curbs on Private Medicare Advantage Plans

Medicare Advantage or Just Medicare?

InnovationRx: Medicare Advantage Plans Are Expanding; Plus: A Medtech Billionaire

Fixed vial sizes for controversial Alzheimer's drug could waste $605 million in Medicare spending each year

Prices Paid to Hospitals by Private Insurers Were 224% of What Medicare Would Pay in 2020

Medicare Advantage Plans Often Deny Needed Care, Federal Report Finds

The FDA Approved a New Drug To Treat Alzheimer’s, but Medicare Won’t Always Pay for It – A Doctor Explains Biogen’s Aduhelm

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

Medicare Will Soon Provide Free At-Home Coronavirus Tests

Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelm

Medicare Extends Telehealth Coverage, a Lifeline for Older Americans

Changes in disparities in access to care, health after Medicare eligibility

Primary care payment model, telemedicine use for Medicare Advantage during pandemic

Comparing spending on common generic drugs by Medicare vs Costco members

Biogen Exec Denies That New Alzheimer’s Medicine Will Overwhelm Medicare — But Experts Disagree

Association of Medicare Advantage star ratings with disparities in quality of care

Most Americans support Medicare negotiation despite claims it would hurt innovation

Social connectedness among medicare beneficiaries after onset of pandemic